Yang; Bing-Shiou

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yang; Bing-Shiou.The latest application filed is for "process of reworking".

Company Profile

4.14.32

Yang; Bing-Shiou - Southbury CT
Yang; Bing-Shiou - Dayton NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Solid forms of a GlyT1 inhibitor Grant 11,447,474 - Gao , et al. September 20, 2	2022-09-20
Process Of Reworking App 20220112183 - GRIMM; Julia Regina ; et al.	2022-04-14
Synthesis Of 1:1:1 Co-crystal Of 1-cyano-2-(4-cyclopropyl-benzyl)-4-( -d-glucopyranos-1-yl)-benzene, L-proline And Water App 20220081461 - ECKHARDT; Matthias ; et al.	2022-03-17
Synthesis of 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(.beta.-D-glucopyranos-1-yl)-benzene, L-proline and water Grant 11,225,500 - Eckhardt , et al. January 18, 2	2022-01-18
Synthesis Of 1:1:1 Co-crystal Of 1-cyano-2-(4-cyclopropyl-benzyl)-4-( -d-glucopyranos-1-yl)-benzene, L-proline And Water App 20210139520 - ECKHARDT; Matthias ; et al.	2021-05-13
Solid Forms of a GlyT1 Inhibitor App 20200347041 - GAO; Joe Ju ; et al.	2020-11-05
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma Grant 10,745,411 - Pouzet , et al. A	2020-08-18
Novel Piperidino-dihydrothienopyrimidine Sulfoxides And Their Use For Treating Copd And Asthma App 20200048278 - POUZET; Pascale Arielle Jane-Josee ; et al.	2020-02-13
Novel Piperidino-dihydrothienopyrimidine Sulfoxides And Their Use For Treating Copd And Asthma App 20180072754 - POUZET; Pascale Arielle Jane-Josee ; et al.	2018-03-15
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma Grant 9,802,954 - Pouzet , et al. October 31, 2	2017-10-31
Novel Piperidino-dihydrothienopyrimidine Sulfoxides And Their Use For Treating Copd And Asthma App 20170008903 - POUZET; Pascale A.J. ; et al.	2017-01-12
Crystalline salts of a potent HCV inhibitor Grant 9,382,240 - Yang , et al. July 5, 2	2016-07-05
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma Grant 9,150,586 - Pouzet , et al. October 6, 2	2015-10-06
Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline Grant 9,120,769 - Eckhardt , et al. September 1, 2	2015-09-01
Crystalline Salts of a Potent HCV Inhibitor App 20150166530 - YANG; Bing-Shiou ; et al.	2015-06-18
Novel Piperidino-dihydrothienopyrimidine Sulfoxides And Their Use For Treating Copd And Asthma App 20150148322 - Pouzet; Pascale A.J. ; et al.	2015-05-28
Novel Piperidino-dihydrothienopyrimidine Sulfoxides And Their Use For Treating Copd And Asthma App 20150045376 - POUZET; Pascale A.J. ; et al.	2015-02-12
Aryl-and Heteroarylcarbonyl Derivatives Of Hexahydroindenopyridine And Octahydrobenzoquinoline App 20140249174 - Eckhardt; Matthias ; et al.	2014-09-04
Solid State Forms Of Hiv Inhibitor App 20140094486 - LI; Zheng Jane ; et al.	2014-04-03
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma Grant 8,609,670 - Pouzet , et al. December 17, 2	2013-12-17
Crystalline Salts of a Potent HCV Inhibitor App 20130317061 - YANG; Bing-Shiou ; et al.	2013-11-28
Mesylate Salt Forms Of A Potent Hcv Inhibitor App 20130261134 - LI; Zhibin ; et al.	2013-10-03
Crystalline salts of a potent HCV inhibitor Grant 8,530,497 - Yang , et al. September 10, 2	2013-09-10
Stereoselective Synthesis Of Tapentadol And Its Salts App 20130150622 - FANDRICK; Daniel Robert ; et al.	2013-06-13
Novel Piperidino-dihydrothienopyrimidine Sulfoxides And Their Use For Treating Copd And Asthma App 20130079359 - POUZET; Pascale A.J. ; et al.	2013-03-28
Novel Piperidino-dihydrothienopyrimidine Sulfoxides And Their Use For Treating Copd And Asthma App 20130059866 - Dollinger; Horst ; et al.	2013-03-07
Novel Salts Forms Of Pyrimidin-5-yl Acetic Acid Derivative App 20120302584 - Yang; Bing-Shiou	2012-11-29
Aryl-and Heteroarylcarbonyl Derivatives Of Hexahydroindenopyridine And Octahydrobenzoquinoline App 20120157488 - Eckhardt; Matthias ; et al.	2012-06-21
Crystalline Salts of a Potent HCV Inhibitor App 20120059033 - YANG; Bing-Shiou ; et al.	2012-03-08
Process For Preparing A Polymorph Of The Choline Salt Of A Pyrimidin-5-yl Acetic Acid Derivative App 20110294828 - Krishnamurthy; Dhileepkumar ; et al.	2011-12-01
Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphon- ooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine Grant 7,851,476 - Chen , et al. December 14, 2	2010-12-14
Crystalline Forms Of A Factor Xa Inhibitor App 20080188517 - Orwat; Michael J. ; et al.	2008-08-07
Crystalline forms of a factor Xa inhibitor Grant 7,371,864 - Orwat , et al. May 13, 2	2008-05-13
Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphon- ooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine App 20070155702 - Chen; Chung-Pin H. ; et al.	2007-07-05
Crystallization via high-shear transformation App 20060160841 - Wei; Chenkou ; et al.	2006-07-20
Crystalline forms of a factor Xa inhibitor App 20060148846 - Orwat; Michael J. ; et al.	2006-07-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.